Heat Biologics, Inc. (Heat) announced that it plans to change its listing from the Nasdaq Capital Market to the NYSE American stock exchange. Heat expects to commence trading as an NYSE American-listed company when markets open on February 14, 2022. The Company’s common stock will continue to trade under its existing “HTBX” symbol. The Company will continue to trade on the Nasdaq Capital Market until the close of market on February 11, 2022.